New procedure treating rare blood cancer a Queensland first

Read time

Man receiving new rare blood cancer treatment
Clinical Nurse Consultant Kylie Stevens, Director of Haematology Professor Craig Wallington-Gates and Clinical Nurse Alex Thorpe conducting new red blood cell apheresis procedure.

A new blood cancer procedure has been launched at the Sunshine Coast University Hospital allowing patients to access the advanced treatment closer to home. 

The Apheresis treatment is now being used for patients diagnosed with Polycythemia Rubra Vera (PRV), a non-aggressive blood cancer where the bone marrow produces too many red blood cells. 

Sunshine Coast Health Director of Haematology Professor Craig Wallington-Gates said the new procedure is more efficient than previous methods. 

"Traditionally, we'd do a procedure known as venesection where a needle is inserted into a patient's arm and through gravity, about 500ml of whole blood is removed and which reduces the number of red blood cells in the circulation," he said. 

"This is an advanced technique called Apheresis, which means removing components of the blood from the circulation and in this case we're removing red blood cells in a very direct manner."

Professor Wallington-Gates said the treatment works incredibly quickly. 

"This results in more fluid blood, that's not so thick and doesn't clot easily and it's an effective means of treating the patients bone marrow disorder."

"Some patients might need it initially on a weekly basis, some patients might need it every six-months and some patients may never need it again." 

The Sunshine Coast University Hospital is just the second site in Australia to offer the treatment, with Barwon Health in Victoria also providing it. 

Sunshine Coast Health Clinical Nurse Consultant Kylie Stevens said the treatment should provide patients with a better outcome. 

"We'll put them onto the machine and it's about an 8 to 15 minute procedure," she said. 

"The patient should hopefully not feel as fatigued post [treatment] because we are replacing them with albumin product from blood bank, and hopefully as we go we will have less frequency in visits."

Sunshine Coast Health began using Apheresis equipment in 2025 as part of its stem cell transplantation service for treating certain aggressive blood cancers. The service has now expanded to support the treatment of additional conditions.

Sunshine Coast Health Chief Executive Peter Gillies said the service was a welcomed addition to the hospital. 

"Being able to offer this treatment locally means patients can receive leading care close to home," Dr Gillies said.

"It's a great example of our clinical teams continuing to innovate and bring new services to our community and reflects our commitment to providing safe and high-quality care for our patients."